16-81365030-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_022041.4(GAN):​c.1293C>T​(p.Tyr431Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.225 in 1,612,604 control chromosomes in the GnomAD database, including 43,257 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3607 hom., cov: 31)
Exomes 𝑓: 0.23 ( 39650 hom. )

Consequence

GAN
NM_022041.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.193

Publications

19 publications found
Variant links:
Genes affected
GAN (HGNC:4137): (gigaxonin) This gene encodes a member of the cytoskeletal BTB/kelch (Broad-Complex, Tramtrack and Bric a brac) repeat family. The encoded protein plays a role in neurofilament architecture and is involved in mediating the ubiquitination and degradation of some proteins. Defects in this gene are a cause of giant axonal neuropathy (GAN). [provided by RefSeq, Oct 2008]
GAN Gene-Disease associations (from GenCC):
  • giant axonal neuropathy 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 16-81365030-C-T is Benign according to our data. Variant chr16-81365030-C-T is described in ClinVar as Benign. ClinVar VariationId is 129131.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.193 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.248 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GANNM_022041.4 linkc.1293C>T p.Tyr431Tyr synonymous_variant Exon 8 of 11 ENST00000648994.2 NP_071324.1
GANNM_001377486.1 linkc.654C>T p.Tyr218Tyr synonymous_variant Exon 7 of 10 NP_001364415.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GANENST00000648994.2 linkc.1293C>T p.Tyr431Tyr synonymous_variant Exon 8 of 11 NM_022041.4 ENSP00000497351.1

Frequencies

GnomAD3 genomes
AF:
0.211
AC:
32041
AN:
151902
Hom.:
3606
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.189
Gnomad AMI
AF:
0.184
Gnomad AMR
AF:
0.172
Gnomad ASJ
AF:
0.203
Gnomad EAS
AF:
0.0350
Gnomad SAS
AF:
0.147
Gnomad FIN
AF:
0.212
Gnomad MID
AF:
0.212
Gnomad NFE
AF:
0.252
Gnomad OTH
AF:
0.222
GnomAD2 exomes
AF:
0.194
AC:
48729
AN:
251396
AF XY:
0.197
show subpopulations
Gnomad AFR exome
AF:
0.188
Gnomad AMR exome
AF:
0.123
Gnomad ASJ exome
AF:
0.208
Gnomad EAS exome
AF:
0.0287
Gnomad FIN exome
AF:
0.215
Gnomad NFE exome
AF:
0.250
Gnomad OTH exome
AF:
0.214
GnomAD4 exome
AF:
0.227
AC:
331134
AN:
1460584
Hom.:
39650
Cov.:
33
AF XY:
0.226
AC XY:
163925
AN XY:
726616
show subpopulations
African (AFR)
AF:
0.185
AC:
6181
AN:
33452
American (AMR)
AF:
0.128
AC:
5746
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.202
AC:
5276
AN:
26134
East Asian (EAS)
AF:
0.0417
AC:
1655
AN:
39696
South Asian (SAS)
AF:
0.149
AC:
12846
AN:
86234
European-Finnish (FIN)
AF:
0.215
AC:
11507
AN:
53410
Middle Eastern (MID)
AF:
0.194
AC:
1115
AN:
5756
European-Non Finnish (NFE)
AF:
0.247
AC:
274066
AN:
1110820
Other (OTH)
AF:
0.211
AC:
12742
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
12804
25608
38411
51215
64019
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9050
18100
27150
36200
45250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.211
AC:
32058
AN:
152020
Hom.:
3607
Cov.:
31
AF XY:
0.206
AC XY:
15293
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.189
AC:
7817
AN:
41464
American (AMR)
AF:
0.171
AC:
2618
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.203
AC:
706
AN:
3470
East Asian (EAS)
AF:
0.0349
AC:
180
AN:
5164
South Asian (SAS)
AF:
0.147
AC:
708
AN:
4818
European-Finnish (FIN)
AF:
0.212
AC:
2241
AN:
10550
Middle Eastern (MID)
AF:
0.204
AC:
60
AN:
294
European-Non Finnish (NFE)
AF:
0.252
AC:
17095
AN:
67964
Other (OTH)
AF:
0.221
AC:
465
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1278
2557
3835
5114
6392
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
340
680
1020
1360
1700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.235
Hom.:
7817
Bravo
AF:
0.203
Asia WGS
AF:
0.111
AC:
389
AN:
3478
EpiCase
AF:
0.253
EpiControl
AF:
0.258

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Giant axonal neuropathy 1 Benign:4
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Oct 09, 2014
ClinVar Staff, National Center for Biotechnology Information (NCBI)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

This SCV is no longer cited in the GeneReview (NBK1136). -

not specified Benign:2
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
0.98
DANN
Benign
0.25
PhyloP100
0.19
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2608555; hg19: chr16-81398635; COSMIC: COSV73720899; COSMIC: COSV73720899; API